Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial

Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial

Abstract Background Phobic anxiety disorders are among the most prevalent psychiatric disorders and are burdensome in terms of loss of quality of life and work productivity. Evidence-based treatments are relatively successful in the majority of patients, especially exposure therapy. However, a subst...

Full description

Bibliographic Details
Main Authors: Febe E. van der Flier, Caroline M. B. Kwee, Danielle C. Cath, Neeltje M. Batelaan, Lucianne Groenink, Puck Duits, Date C. van der Veen, Anton J. L. M. van Balkom, Johanna M. P. Baas
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Psychiatry
Subjects:
Anxiety disorders
Panic disorder with agoraphobia
Social phobia
Cannabidiol
Exposure therapy
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s12888-019-2022-x

Internet

http://link.springer.com/article/10.1186/s12888-019-2022-x

Similar Items